Bombay Oxygen

Why is Bombay Oxygen Investments Ltd falling/rising?

As of 11-Jun, the stock price of Bombay Oxygen Investments Ltd is currently at Rs 19,398.00, reflecting a short-term increase despite a year-to-date decline of 13.93% and a 1-year decline of 22.71%. The stock's recent rise is accompanied by decreased investor participation, suggesting caution among investors.

As of 11-Jun, the stock price of Bombay Oxygen Investments Ltd is rising, currently at Rs 19,398.00, reflecting an increase of Rs 331.0 or 1.74%. This rise can be attributed to its performance today, where it outperformed the sector by 2.87%. Additionally, the stock is currently higher than its 5-day moving averages, indicating a short-term positive trend. <BR><BR>However, it is important to note that despite the current rise, the stock has experienced a decline over longer periods, with a year-to-date decrease of 13.93% and a 1-year decline of 22.71%. Furthermore, the stock is still 4.63% away from its 52-week low, suggesting that while there is a short-term uptick, the overall performance remains under pressure. The falling investor participation, with a delivery volume decrease of 35.19% against the 5-day average, may also indicate caution among investors despite the recent price increase.

What does Bombay Oxygen do?

Bombay Oxygen Investments Ltd is a micro-cap Non-Banking Financial Company (NBFC) established in 1960, focusing on investments. As of March 2026, it reported net sales of -36 Cr and a net profit of -31 Cr, with a market cap of INR 289 Cr.

Overview:<BR>Bombay Oxygen Investments Ltd is a Non-Banking Financial Company (NBFC) operating in the micro-cap segment.<BR><BR>History:<BR>The company was incorporated in October 1960 and was originally known as Bombay Oxygen Corporation. It changed its name to Bombay Oxygen Investments Ltd on 3rd October 2018. The latest quarterly results reported are for March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: -36 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: -31 Cr (Quarterly Results - Mar 2026) <BR>Market cap: INR 289 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 22 <BR>Dividend Yield: 0.18% <BR>Debt Equity: 0.00 <BR>Return on Equity: -0.69% <BR>Price to Book: 0.61<BR><BR>Contact Details:<BR>Address: 22/B Mittal Tower, 210 Nariman Point Mumbai Maharashtra : 400021 <BR>Tel: 91-022-66107503-08 <BR>Email: bomoxy@mtnl.net.in <BR>Website: http://www.bomoxy.com

Which are the latest news on Bombay Oxygen?

How big is Bombay Oxygen?

As of 10th June, Bombay Oxygen Investments Ltd has a market capitalization of 289.00 Cr, classifying it as a Micro Cap company, with recent net sales of 39.26 Cr and net profit of 2.61 Cr over the latest four quarters. Shareholder's funds and total assets data are not available.

As of 10th June, <BR><BR>Market Cap: Bombay Oxygen Investments Ltd has a market capitalization of 289.00 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 39.26 Cr, while the sum of Net Profit for the same period is 2.61 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is not specified, and the values for Shareholder's Funds and Total Assets are not available.

Who are in the management team of Bombay Oxygen?

The management team of Bombay Oxygen includes Shyam M Ruia (Chairman), Mohan Bir Singh, Nirmal P Jhunjhunwala, Aruna Kantikumar Kanoria (all Independent Directors), Sangeeta Rohit Naik (Company Secretary), Hema Reganathan (Whole-time Director), and Vikas Mukesh Jain (Director).

The management team of Bombay Oxygen includes the following individuals:<BR><BR>1. **Shyam M Ruia** - Chairman (Non-Executive)<BR>2. **Mohan Bir Singh** - Independent Director<BR>3. **Nirmal P Jhunjhunwala** - Independent Director<BR>4. **Aruna Kantikumar Kanoria** - Independent Director<BR>5. **Sangeeta Rohit Naik** - Company Secretary & Compliance Officer<BR>6. **Hema Reganathan** - Whole-time Director<BR>7. **Vikas Mukesh Jain** - Director<BR><BR>If you need more details about any specific member or their roles, feel free to ask!

Who are the peers of the Bombay Oxygen?

Bombay Oxygen's peers include Indl. Inv. Trust, Stellant Secu., Regency Fincorp, and others, with varying management and growth risks. Its 1-year return is -24.30%, better than Last Mile Enter. (-60.43%) but worse than Stellant Secu. (178.40%).

Peers: The peers of Bombay Oxygen are Indl. Inv. Trust, Stellant Secu., Regency Fincorp, Fundviser Capit., Last Mile Enter., Avonmore Capital, P. H. Capital, U. Y. Fincorp, and Sera Investments.<BR><BR>Quality Snapshot: Excellent management risk is observed at Indl. Inv. Trust, Stellant Secu., Regency Fincorp, Fundviser Capit., Last Mile Enter., U. Y. Fincorp, and Sera Investments, while Average management risk is found at Bombay Oxygen, Avonmore Capital, P. H. Capital, and the rest. Below Average management risk is noted at the remaining peers. Growth is Excellent for Stellant Secu., Regency Fincorp, Last Mile Enter., U. Y. Fincorp, and Sera Investments, while Average growth is seen at Indl. Inv. Trust, and the rest. Below Average growth is present at Bombay Oxygen, Fundviser Capit., Avonmore Capital, and P. H. Capital. Capital Structure is Excellent for Indl. Inv. Trust, Stellant Secu., Regency Fincorp, Bombay Oxygen, Last Mile Enter., Avonmore Capital, P. H. Capital, U. Y. Fincorp, Sera Investments, and the rest, while Below Average is noted for Fundviser Capit.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Stellant Secu. at 178.40%, while the lowest is Last Mile Enter. at -60.43%. Bombay Oxygen's own 1-year return is -24.30%, which is higher than Last Mile Enter. but lower than Stellant Secu. Additionally, peers with negative six-month returns include Last Mile Enter., Avonmore Capital, and U. Y. Fincorp.

Should I buy, sell or hold Bombay Oxygen Investments Ltd?

When is the next results date for Bombay Oxygen Investments Ltd?

The next results date for Bombay Oxygen Investments Ltd is 27 May 2026.

The next results date for Bombay Oxygen Investments Ltd is scheduled for 27 May 2026.

Is Bombay Oxygen overvalued or undervalued?

As of November 3, 2025, Bombay Oxygen is considered risky and overvalued, with a PE ratio of -42.06 and poor financial metrics compared to peers like Linde India and Petronet LNG, alongside a year-to-date stock performance of -16.78%, significantly underperforming the Sensex's 7.47% gain.

As of 3 November 2025, the valuation grade for Bombay Oxygen has moved from very expensive to risky. The company is currently assessed as overvalued. Key ratios indicate significant financial distress, with a PE ratio of -42.06, an EV to EBITDA of -32.75, and a Price to Book Value of just 0.07, highlighting the company's struggles in generating profits and managing its capital effectively.<BR><BR>In comparison to its peers, Bombay Oxygen's valuation metrics are starkly unfavorable. For instance, Linde India, categorized as very expensive, has a PE ratio of 114.15, while Petronet LNG, rated very attractive, boasts a PE of 11.54. The stark contrast in these ratios underscores the challenges faced by Bombay Oxygen in the current market landscape. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -16.78%, significantly lagging behind the Sensex's gain of 7.47% during the same period.

How has been the historical performance of Bombay Oxygen?

Bombay Oxygen's historical performance from 2009 to 2011 shows consistent growth in net sales and profits, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities declined from 3.74 Cr to -0.42 Cr, indicating cash management challenges despite overall profitability.

Answer:<BR>The historical performance of Bombay Oxygen shows a steady increase in net sales and profit over the years from 2009 to 2011.<BR><BR>Breakdown:<BR>Bombay Oxygen's net sales rose from 32.51 Cr in March 2009 to 41.74 Cr in March 2011, indicating a consistent growth trend. The total operating income mirrored this increase, reaching 41.74 Cr in March 2011, up from 32.51 Cr in March 2009. The company's operating profit (PBDIT) also improved significantly, growing from 4.59 Cr in March 2009 to 8.84 Cr in March 2011. Profit before tax followed a similar upward trajectory, increasing from 0.90 Cr in March 2009 to 5.24 Cr in March 2011, while profit after tax rose from 0.59 Cr to 4.15 Cr in the same period. The earnings per share (EPS) saw a remarkable rise from 39.13 in March 2009 to 276.4 in March 2011. However, cash flow from operating activities showed a decline, moving from 3.74 Cr in March 2009 to -0.42 Cr in March 2011, reflecting challenges in cash generation despite the growth in profits. Overall, the financial metrics indicate a positive trend in revenue and profitability, although cash flow management appears to have faced difficulties.

Are Bombay Oxygen latest results good or bad?

The latest results for Bombay Oxygen are bad, showing a net loss of ₹5.22 crore in Q2 FY26 and a 56.23% decline in revenue compared to last year, along with a significant drop in return on equity and operating margin. Overall, the company is facing serious financial challenges.

The latest results for Bombay Oxygen indicate a challenging financial situation. In Q2 FY26, the company reported a net loss of ₹5.22 crore, marking a significant downturn as it has transitioned into an NBFC. The revenue for the first half of FY26 was ₹23.19 crore, which represents a dramatic decline of 56.23% compared to the same period last year.<BR><BR>Additionally, the company's return on equity (ROE) has dropped to 3.08%, well below its historical average of 10.77%, highlighting serious concerns about capital efficiency. The operating margin has also contracted significantly, falling to 5.53% from 22.76% in the previous quarter.<BR><BR>Overall, these results reflect a negative financial trend, with the company struggling to generate consistent returns and facing operational challenges. The investment case for Bombay Oxygen appears to have deteriorated substantially, suggesting that the latest results are indeed bad.

Who are the top shareholders of the Bombay Oxygen?

The top shareholder of Bombay Oxygen is M Ramnarain Pvt. Ltd. with a 22.41% stake, followed by Shubh Pharma Pvt. Ltd. at 3.75%. Individual investors hold 14.98%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Bombay Oxygen include M Ramnarain Pvt. Ltd., which holds the highest stake at 22.41%. The company is primarily owned by its promoters, and there are no pledged promoter holdings. In terms of public shareholders, Shubh Pharma Pvt. Ltd. is the largest, owning 3.75%. Additionally, individual investors collectively hold 14.98% of the shares. Notably, there are currently no mutual funds or foreign institutional investors involved with the company.

What is the technical trend for Bombay Oxygen?

As of May 12, 2025, Bombay Oxygen's technical trend is mildly bearish, with mixed signals from the MACD and RSI, while daily moving averages and OBV reinforce the overall bearish sentiment.

As of 12 May 2025, the technical trend for Bombay Oxygen has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals. The RSI shows no signal on the weekly chart but is bearish on the monthly, reinforcing the overall bearish sentiment. Moving averages on the daily chart are mildly bearish, and the KST aligns with the MACD, being mildly bullish weekly but bearish monthly. The OBV is consistently mildly bearish on both weekly and monthly time frames. Overall, the current technical stance is mildly bearish, with key indicators such as the daily moving averages and monthly RSI contributing to this outlook.

Has Bombay Oxygen declared dividend?

Yes, Bombay Oxygen Investments Ltd has declared a 25% dividend, amounting to 25 per share, with an ex-date of August 6, 2024. The dividend yield is 0.1%, and total returns have varied significantly across different periods, showing strong long-term performance despite recent declines.

Bombay Oxygen Investments Ltd has declared a 25% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 25%<BR>- Amount per share: 25<BR>- Ex-date: 06 Aug 24<BR><BR>Dividend Yield: 0.1%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -23.2%, with a dividend return of 0%, resulting in a total return of -23.2%.<BR><BR>Over the past year, the price return was 32.4%, with a dividend return of 0.13%, leading to a total return of 32.53%.<BR><BR>In the 2-year period, the price return stood at 124.78%, with a dividend return of 0.36%, culminating in a total return of 125.14%.<BR><BR>For the 3-year period, the price return was 93.44%, with a dividend return of 0.51%, resulting in a total return of 93.95%.<BR><BR>In the last 4 years, the price return was 83.04%, with a dividend return of 0.58%, leading to a total return of 83.62%.<BR><BR>Finally, over the past 5 years, the price return was 111.24%, with a dividend return of 0.80%, resulting in a total return of 112.04%.<BR><BR>Overall, Bombay Oxygen has declared a dividend, and while the dividend yield is relatively low, the total returns over various periods show significant variability, with strong performance in the longer term despite recent declines in the short term.